IMR Press / FBL / Volume 19 / Issue 3 / DOI: 10.2741/4216

Frontiers in Bioscience-Landmark (FBL) is published by IMR Press from Volume 26 Issue 5 (2021). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on imrpress.com as a courtesy and upon agreement with Frontiers in Bioscience.

Review
Physiological and pathological implications of cholesterol
Show Less
1 Departmento de Nutricion, Diabetes y Metabolismo, Escuela de Medicina, Facultad of Medicina, Pontificia Universidad Catolica de Chile, Santiago, Chile
2 Departmento de Gastroenterologia, Escuela de Medicina, Facultad of Medicina, Pontificia Universidad Catolica de Chile, Santiago, Chile
Front. Biosci. (Landmark Ed) 2014, 19(3), 416–428; https://doi.org/10.2741/4216
Published: 1 January 2014
Abstract

Cholesterol has evolved to fulfill sophisticated biophysical, cell signaling and endocrine requirements of animal systems. At a cellular level, cholesterol is found in membranes, where it increases both bilayer stiffness and impermeability to water and ions. Furthermore, cholesterol is integrated into specialized lipid-protein membrane microdomains with critical topographical and signaling functions. At an organismal level, cholesterol is the precursor for all steroid hormones, including gluco- and mineralo-corticoids, sex hormones and vitamin D, all of which regulate carbohydrate, sodium, reproductive and bone homeostasis, respectively. This sterol is also the precursor for bile acids, which are important for intestinal absorption of dietary lipids as well as energy and glucose metabolic regulation. Importantly, complex mechanisms maintain cholesterol within physiological ranges and the disregulation of these mechanisms results in embryonic or adult diseases, caused by either excessive or reduced tissue cholesterol levels. The causative role of cholesterol in these diseases has been demonstrated by diverse genetic and pharmacologic animal models that are commented in this review.

Keywords
Cholesterol
Membrane
Mevalonate pathway
Atherosclerosis
Malformation
Development
Review
Share
Back to top